|
Information was received from a healthcare provider (hcp) via a manufacturer's representative (rep) regarding a patient receiving li oresal (500mcg/ml at 75mcg/day) via an implantable infusion pump for unknown indications for use.It was reported that the patient's pump and catheter were replaced due to a possible infection at the pocket site.Environmental, external, and patient factors that may have contributed to this event were unknown.Diagnostics were unknown.Part of the catheter spine segment remains in place, but is not in use.The issue was resolved at the time of the report.
|
|
Continuation of d10: product id 8780 lot# serial# hg90a6a10 implanted: 2026-08-21 explanted: (b)(6) 2026.Product type catheter section d information references the main component of the system.Other relevant device(s) are: product id: 8780, serial/lot #: hg90a6a10, ubd: (b)(6)2027, udi#: (b)(4) medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|